Interleukin-18 Up-Regulates Osteoprotegerin Expression in Stromal/Osteoblastic Cells
- 1 February 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 281 (2) , 361-366
- https://doi.org/10.1006/bbrc.2001.4380
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-κB Ligand: Modulation of the Expression by Osteotropic Factors and CytokinesBiochemical and Biophysical Research Communications, 2000
- The Osteoblast-specific Transcription Factor Cbfa1 Contributes to the Expression of Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and FunctionJournal of Biological Chemistry, 2000
- The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone ResorptionJournal of Bone and Mineral Research, 2000
- Defective Interleukin (IL)-18–mediated Natural Killer and T Helper Cell Type 1 Responses in IL-1 Receptor–associated Kinase (IRAK)-deficient MiceThe Journal of Experimental Medicine, 1999
- Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like CellsBiochemical and Biophysical Research Communications, 1998
- Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal CellsJournal of Biological Chemistry, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.Journal of Clinical Investigation, 1998
- Interleukin-18 Induces Activation and Association of p56lck and MAPK in a Murine TH1 CloneBiochemical and Biophysical Research Communications, 1997
- Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast FormationThe Journal of Experimental Medicine, 1997